Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01133990
What this trial is testing

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eisai Inc. 5
Early research (Phase 1)Looking for participantsNCT06696768
What this trial is testing

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT01987726
What this trial is testing

Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors

Who this might be right for
Recurrent Breast CancerRecurrent Colon CancerRecurrent Rectal Cancer+5 more
Ohio State University Comprehensive Cancer Center 150
Not applicableStudy completedNCT02887235
What this trial is testing

Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

Who this might be right for
Quality of Life
NYU Langone Health 6
Not applicableNot Yet RecruitingNCT07474025
What this trial is testing

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Who this might be right for
Peritoneal (Metastatic) CancerColorectal CancerColorectal (Colon or Rectal) Cancer+1 more
Jules Bordet Institute 30
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Early research (Phase 1)UnknownNCT03310008
What this trial is testing

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 36
Large-scale testing (Phase 3)Study completedNCT00008060
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council
Testing effectiveness (Phase 2)Active Not RecruitingNCT06106308
What this trial is testing

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Who this might be right for
Metastatic Colorectal CancerCRCKRAS/NRAS Mutation
Cardiff Oncology 110
Testing effectiveness (Phase 2)Looking for participantsNCT06992258
What this trial is testing

Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Criterium, Inc. 120
Early research (Phase 1)Ended earlyNCT02550743
What this trial is testing

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

Who this might be right for
Rectal Cancer
howard safran 7
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT02119676
What this trial is testing

Study of Ruxolitinib in Colorectal Cancer Patients

Who this might be right for
CRC (Colorectal Cancer)
Incyte Corporation 396
Testing effectiveness (Phase 2)Study completedNCT01900717
What this trial is testing

Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20)

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Centre Hospitalier Universitaire Dijon 102
Not applicableNot Yet RecruitingNCT06552117
What this trial is testing

ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer ( MetaIRM)

Who this might be right for
Colorectal Cancer With Liver Metastases
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591597
What this trial is testing

A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer

Who this might be right for
Metastatic Colorectal NeoplasmsMicrosatellite Stable / Proficient Mismatch Repair Colorectal Cancer
National Cancer Center Hospital East 68
Testing effectiveness (Phase 2)Looking for participantsNCT07789210
What this trial is testing

A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases

Who this might be right for
Colorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more
Zhejiang University 25
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07061210
What this trial is testing

An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Fudan University 20
Next Page